US Stock MarketDetailed Quotes
DMAC DiaMedica Therapeutics
- 6.410
- +1.540+31.62%
Close Dec 20 16:00 ET
- 5.650
- -0.760-11.86%
Post 19:58 ET
274.10MMarket Cap-11.45P/E (TTM)
6.410High4.750Low265.81KVolume4.760Open4.870Pre Close1.59MTurnover1.10%Turnover RatioLossP/E (Static)42.76MShares6.41052wk High5.71P/B154.51MFloat Cap2.14052wk Low--Dividend TTM24.10MShs Float10.880Historical High--Div YieldTTM34.09%Amplitude1.120Historical Low5.993Avg Price1Lot Size
About DiaMedica Therapeutics Company
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Company Profile
SymbolDMAC
Company NameDiaMedica Therapeutics
Listing DateDec 7, 2018
Issue Price4.00
Founded2000
CEOMr. Rick Pauls
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address301 Carlson Parkway,Suite 210
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55305
Phone1-763-496-5454
Websitehttp://www.diamedica.com
Company Executives
- Name
- Position
- Salary
- Rick Pauls
- Director, President and Chief Executive Officer
- 1.22M
- Dominic R. Cundari
- Chief Commercial Officer
- --
- Lorianne Musuoka
- Chief Medical Officer
- --
- David J. Wambeke
- Chief Business Officer
- --
- Lorianne Masuoka
- Chief Medical Officer
- --
- Scott Kellen
- Chief Financial Officer, Principal Accounting Officer and Secretary
- 632.22K
- Julie VanOrsdel Daves
- Senior Vice President, Clinical Development Operations
- 533.37K
- Rebekah de Vitry Fries
- Vice President of Clinical Operations
- --
- Richard D. Pilnik
- Chairman of the Board
- 133.98K
- James T. Parsons
- Independent Director
- 97.18K
- Charles Semba, M.D.
- Independent Director
- 89.68K
- Dr. Michael Giuffre, M.D.
- Independent Director
- 90.93K
- Dr. Richard E. Kuntz, M.D.,M.Sc.
- Independent Director
- 96.02K
- Tanya Lewis, M.S.
- Independent Director
- 91.85K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
